Question banks
How will you do?
67% of respondents got this question correct
This question is from the Metabolic Dysfunction-Associated Steatohepatitis (MASH) question bank.
This program is funded by an independent grant from Novo Nordisk. This online education program has been designed solely for healthcare professionals in the USA. The content is not available for healthcare professionals in any other country.
A 40-year-old male with MASH is being monitored after initiating a new treatment regimen for his condition. What biomarker would be most useful to evaluate the immediate effectiveness of his treatment?
A
B
C
D
E